Showing results (111-120 of 273) with videos related to

Sort By:
Pageof 28
European Thyroid Journal|March 30, 2018
Severe Inflammatory Ophthalmopathy in a Euthyroid Patient during Nivolumab TreatmentPauline Campredon, Philippe Imbert, Céline Mouly, et al.
Pituitary|January 12, 2011
Tamoxifen enhances the control of acromegaly treated with somatostatin analog lanreotideJean-Christophe Maiza, Stéphane Castillo-Ros, Maria Matta, et al.
Clinical Endocrinology|January 25, 2006
Effectiveness and tolerability of 3-year lanreotide Autogel treatment in patients with acromegalyPhilippe Caron, Muriel Cogne, Isabelle Raingeard, et al.
International Journal of Cancer|February 22, 2002
Molecular and functional MDR1-Pgp and MRPs expression in human glioblastoma multiforme cell linesXavier Declèves, Anne Fajac, Jacqueline Lehmann-Che, et al.
Clinical Case Reports|December 12, 2017
Severe thyrotoxicosis in an infant revealing familial nonautoimmune hyperthyroidism with a novel (C672W) stimulating thyrotropin receptor germline mutationIsabelle Oliver-Petit, Frédérique Savagner, Solange Grunenwald, et al.
European Journal of Endocrinology|February 27, 2008
Impaired quality of life of patients with acromegaly: control of GH/IGF-I excess improves psychological subscale appearanceMaria P Matta, Elisabeth Couture, Laurent Cazals, et al.
European Journal of Endocrinology|April 8, 2011
Clinical and metabolic characteristics of acromegalic patients with high IGF1/normal GH levels during somatostatin analog treatmentMaria Matta, Vanina Bongard, Solange Grunenwald, et al.
Pageof 28